Global Needle Free Drug Delivery Devices Market US$ 10.5 Billion by 2021

Global Needle Free Drug Delivery Devices Market US$ 10.5 Billion by 2021

According to a market research report Needle Free Drug Delivery Devices Market 2017-2021 published by iHealthcareAnalyst, Inc., the global needle free drug delivery devices market is estimated to reach US$ 9.6 Billion in 2020, expanding at a CAGR of 9.5% from 2017 to 2021.

Visit the Needle Free Drug Delivery Devices Market 2017-2021 report at https://www.ihealthcareanalyst.com/report/needle-free-drug-delivery-devices-market/

The global needle free drug delivery devices market segmentation is based on technology (jet injectors, novel needle-free technology, transdermal patch technology), and its applications (diabetes, paediatrics, pain management, vaccination). The global needle free drug delivery devices market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).

Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. A needle-free delivery device can deliver the drug either actively or passively is a rational alternative. In the case of delivering the drug actively, a driving force is necessary for the transport of drug across the skin, which may be accomplished using jet injectors, electroporation, iontophoresis, ultrasound, powder injection, and tape stripping. Different delivery systems have been developed to deliver vaccine to the epidermal layer of skin.

The global needle free drug delivery devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global needle free drug delivery devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

  1. Technology
    • Jet Injectors
    • Novel needle-free technology
    • Transdermal patch technology
  1. Application
    • Diabetes
    • Paediatrics
    • Pain Management
    • Vaccination
    • Others
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • 3M
    • Antares Pharma, Inc.
    • Glide Pharmaceutical Technologies Ltd.
    • Injex Pharma AG
    • Pharmajet, Inc.
    • Zogenix, Inc.

 About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2017-11-05T10:11:48+00:00 Categories: Press Releases|